Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Outsourcing

Pharmaron to acquire US site from Noramco

by Rick Mullin
June 3, 2022 | A version of this story appeared in Volume 100, Issue 20

 

Pharmaron Beijing, a Chinese drug services firm, has agreed to acquire an active pharmaceutical ingredient (API) manufacturing site in Coventry, Rhode Island, from Noramco. The plant has reactors ranging from kilogram to metric ton scale. It will be the first US API plant for Pharmaron, which has plants in China and the UK. The investment firm SK Capital bought Noramco from Johnson & Johnson in 2016.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.